Published in Br Med J (Clin Res Ed) on April 10, 1982
Lack of a pharmacokinetic interaction between nifedipine and the beta-adrenoceptor blockers metoprolol and atenolol. Br J Clin Pharmacol (1984) 0.95
Tolerability of combined treatment with verapamil and beta-blockers in angina resistant to monotherapy. Postgrad Med J (1985) 0.85
Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects. Br J Clin Pharmacol (1991) 0.75
Verapamil in the treatment of paroxysmal supraventricular tachycardia. Postgrad Med J (1974) 2.08
Verapamil in chronic stable angina. A controlled study with computerized multistage treadmill exercise. Lancet (1980) 2.05
Drugs and the heart. III. Calcium antagonists. Lancet (1980) 1.99
Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris. Circulation (1971) 1.89
Clinical evaluation of verapamil in angina pectoris. Br Med J (1968) 1.85
Double-blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris. Br Med J (1973) 1.76
Physiological disposition of verapamil in man. Cardiovasc Res (1976) 1.71
Effects of intravenous verapamil on hemodynamics in patients with heart disease. Am Heart J (1977) 1.63
IPROVERATRIL: EXPERIMENTAL DATA ON CORONARY DILATATION AND ANTIARRHYTHMIC ACTION. Can Med Assoc J (1964) 1.50
Effects of verapamil on myocardial performance in coronary disease. Circulation (1979) 1.50
Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris. Am J Cardiol (1981) 1.45
Reassessment of failed beta-blocker treatment in angina pectoris by peak-exercise heart rate measurements. Br Med J (1975) 1.38
Drugs and the heart. Lancet (1980) 1.21
Verapamil and the myocardium. Postgrad Med J (1974) 1.18
Double blind evaluation of orally administered iproveratril in patients with angina pectoris. Am J Med Sci (1966) 1.06
Propranolol and isosorbide dinitrate synergism in angina pectoris. Am J Cardiol (1968) 1.04
Some effects of iproveratril (Isoptin) on the cardiovascular system. J Pharmacol Exp Ther (1968) 1.04
Verapamil and norverapamil plasma concentrations during long-term therapy in patients with hypertrophic obstructive cardiomyopathy. J Cardiovasc Pharmacol (1980) 1.03
Verapamil in ischaemic heart disease--quantitative assessment by serial multistage treadmill exercise. Postgrad Med J (1976) 0.99
Asystole after verapamil. Br Med J (1972) 0.98
Regional contractility. Selective depression of ischemic myocardium by verapamil. Circulation (1976) 0.90
Antianginal and myocardial metabolic properties of verapamil in coronary artery disease. Am J Cardiol (1980) 0.90
Verapamil in cardiac arrhythmias. Br Med J (1972) 0.90
Aerobic parameters of exercise as a function of body size during growth in children. J Appl Physiol Respir Environ Exerc Physiol (1984) 2.09
Hereditary spherocytosis associated with deletion of human erythrocyte ankyrin gene on chromosome 8. Nature (1990) 1.99
Epidemiological analysis of tuberculosis treatment outcome as a tool for changing TB control policy in Israel. Isr Med Assoc J (2001) 1.39
Gas exchange response to exercise in children. Am Rev Respir Dis (1984) 1.38
The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients. Cancer Res (1998) 1.38
Cloning and characterization of the human activity-dependent neuroprotective protein. J Biol Chem (2001) 1.30
Do exercise- and antigen-induced asthma utilize the same pathways? Antigen provocation in patients rendered refractory to exercise-induced asthma. J Allergy Clin Immunol (1981) 1.13
Continuous ambulatory electrocardiography in elderly people. BMJ (1995) 1.07
Comparison of the antianginal effectiveness of nifedipine, verapamil, and isosorbide dinitrate in patients receiving propranolol: a double-blind study. Circulation (1983) 1.06
Blast injury of the chest. A review of the problem and its treatment. Isr J Med Sci (1975) 1.04
Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia. Blood (1987) 0.99
Combined spectrin and ankyrin deficiency is common in autosomal dominant hereditary spherocytosis. Blood (1993) 0.97
Experimental intrauterine growth retardation alters renal development. Pediatr Nephrol (2000) 0.96
Hashimoto's disease in a papillary carcinoma of the thyroid originating in a teratoma of the ovary (malignant struma ovarii). Gynecol Endocrinol (1998) 0.95
Multiple brain abscesses caused by Streptococcus bovis. J Infect (1991) 0.93
Growth-related changes in oxygen uptake and heart rate during progressive exercise in children. Pediatr Res (1984) 0.93
The molecular pathobiology of cell membrane iron: the sickle red cell as a model. Free Radic Biol Med (1998) 0.93
Tuberculosis outbreak among students in a boarding school. Eur Respir J (2006) 0.92
Inhibition of erythrocyte Ca2+-ATPase by activated oxygen through thiol- and lipid-dependent mechanisms. Biochim Biophys Acta (1986) 0.91
Evidence that the metabolic acidosis threshold is the anaerobic threshold. J Appl Physiol (1985) (1990) 0.89
A novel signaling molecule for neuropeptide action: activity-dependent neuroprotective protein. Ann N Y Acad Sci (1999) 0.88
Routine two-step skin testing for tuberculosis in the staff of a geriatric hospital in Israel: booster and conversion rates. J Hosp Infect (2000) 0.88
Vascular endothelial growth factor messenger ribonucleic acid expression in human ovarian and endometrial cancer. Gynecol Endocrinol (1996) 0.88
Coupling of ventilation and CO2 production during exercise in children. Pediatr Res (1987) 0.87
Removal of erythrocyte membrane iron in vivo ameliorates the pathobiology of murine thalassemia. J Clin Invest (1997) 0.86
Hyponatremia in myxedema: a suggested therapeutic approach. Isr J Med Sci (1979) 0.86
The effect of intracoronary injection of contrast medium upon coronary blood flow. Circulation (1975) 0.86
Screening and management of tuberculosis in immigrants: the challenge beyond professional competence. Int J Tuberc Lung Dis (2003) 0.85
A novel VIP responsive gene. Activity dependent neuroprotective protein. Ann N Y Acad Sci (2000) 0.85
Pulmonary oedema induced by strenuous swimming: a field study. Respir Physiol (2000) 0.85
Intra-arterial and cuff blood pressure responses during incremental cycle ergometry. Med Sci Sports Exerc (1988) 0.85
Vascular endothelial growth factor. Expression in human vulvar neoplastic and nonneoplastic tissues. J Reprod Med (1996) 0.84
Abnormal erythrocyte calcium homeostasis in oxidant-induced hemolytic disease. Blood (1981) 0.84
Nonrandom association of free iron with membranes of sickle and beta-thalassemic erythrocytes. Blood (1993) 0.83
Complete heart block and seizures in an adult with systemic lupus erythematosus. A possible pathophysiologic role for anti-SS-A/Ro and anti-SS-B/La autoantibodies. Arthritis Rheum (1993) 0.83
Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats. Inflamm Bowel Dis (1999) 0.83
First trimester listeriosis with normal fetal outcome. Eur J Clin Microbiol Infect Dis (1994) 0.83
Impaired erythrocyte calcium homeostasis in beta-thalassemia. Blood (1984) 0.82
Evidence that diffusion limitation determines oxygen uptake kinetics during exercise in humans. J Clin Invest (1990) 0.82
Diabetic ketoacidosis does not precipitate haemolysis in patients with the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency. Br Med J (Clin Res Ed) (1984) 0.82
Near-fatal systemic oxygen embolism due to wound irrigation with hydrogen peroxide. Postgrad Med J (1982) 0.81
Hypoglycemia-induced hemolysis in glucose-6-phosphate dehydrogenase deficiency. Acta Haematol (1985) 0.81
Deferiprone therapy in homozygous human beta-thalassemia removes erythrocyte membrane free iron and reduces KCl cotransport activity. J Lab Clin Med (1999) 0.81
Hemolytic anemia as a complication of acute viral hepatitis in glucose-6-phosphate dehydrogenase-deficient and healthy individuals. Isr J Med Sci (1983) 0.81
The origin of sickle cell alleles in Israel. Hum Genet (1990) 0.81
Calcium transport and ultrastructure of red cells in beta-thalassemia intermedia. Blood (1988) 0.80
Hypernatremia, hypodipsia and partial diabetes inspipidus: a model for defective osmoregulation. Am J Med Sci (1980) 0.80
Control of breathing at the start of exercise as influenced by posture. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.80
Treadmill exercise testing, part II. Curr Probl Cardiol (1977) 0.80
The additive antianginal action of oral isosorbide dinitrate in patients receiving propranolol. Magnitude and duration of effect. Chest (1983) 0.80
[A national qualifying internal medicine examination for Israeli medical students]. Harefuah (1995) 0.79
Preleukemia in acute lymphoblastic leukemia. Acta Haematol (1981) 0.79
A femtomolar-acting neuroprotective peptide induces increased levels of heat shock protein 60 in rat cortical neurons: a potential neuroprotective mechanism. Neurosci Lett (1999) 0.79
Erythrocyte membrane alterations in beta-thalassaemia. Clin Haematol (1985) 0.79
Dexamethasone for acute radiation encephalopathy. Lancet (1978) 0.79
Competitive binding assay for quantitative determination of GM1 ganglioside in plasma and cerebrospinal fluid. J Pharm Biomed Anal (1992) 0.79
Tumour of the nose as a presenting feature of leukaemia. J Laryngol Otol (1982) 0.79
Orally administered glycolipid derivative LIGA20 reduces infarct volume and behavioral impairment after focal cerebral ischemia. J Pharmacol Exp Ther (1994) 0.78
Failure of propranolol to improve exercise tolerance in patients with mitral stenosis in sinus rhythm. Br Heart J (1987) 0.78
Desferrioxamine (DFO) conjugated with starch decreases NAD redox potential of intact red blood cells (RBC): evidence for DFO as an extracellular inducer of oxidant stress in RBC. Am J Hematol (2000) 0.78
The new National Tuberculosis Control Programme in Israel, a country of high immigration. Int J Tuberc Lung Dis (2003) 0.78
Vasoactive intestinal peptide. Link between electrical activity and glia-mediated neurotrophism. Ann N Y Acad Sci (1999) 0.78
Effects of growth hormone and growth hormone-releasing hormone on steroid synthesis in cultured human luteinizing granulosa cells. Gynecol Endocrinol (1996) 0.78
Premature ovarian failure: steroid synthesis and autoimmunity. Gynecol Endocrinol (1998) 0.78
In controlled ovarian hyperstimulation, steroid production, oocyte retrieval, and pregnancy rate correlate with gene expression of vascular endothelial growth factor. J Assist Reprod Genet (1997) 0.78
The additive antianginal action of oral nifedipine in patients receiving propranolol: magnitude and duration of effect. Circulation (1982) 0.78
Increasing the bandwidth of resonant gravitational antennas: the case of explorer. Phys Rev Lett (2003) 0.77
Risk indicators after envenomation in humans by Echis coloratus (mid-east saw scaled viper). Toxicon (1992) 0.76
Expression of vascular endothelial growth factor in human luteinizing granulosa cells and its correlation with the response to controlled ovarian hyperstimulation. Gynecol Endocrinol (1997) 0.76
Thrombotic thrombocytopenic purpura associated with Bacteroides bacteremia. Arch Intern Med (1981) 0.76
Methyldopa-induced immune hemolytic anemia and chronic active hepatitis. Arch Intern Med (1983) 0.75
Coronary heart disease in women. N Engl J Med (2000) 0.75
Reduction of air leaks after resection of emphysematous lung. Ann Thorac Surg (1995) 0.75
Walking through angina. Br Med J (Clin Res Ed) (1985) 0.75
Long-acting nitrates in the prophylaxis of angina pectoris. Br Med J (1979) 0.75
Quality of life after myocardial infarction: Canada versus the United States. N Engl J Med (1995) 0.75
The antianginal effect of isosorbide mononitrate. Am J Cardiol (1994) 0.75
Gout and amyloidosis. Ann Rheum Dis (1980) 0.75
Survival benefit of trandolapril. Lancet (1999) 0.75
Treating hypercholesterolemia--without the hype. Am J Cardiol (1997) 0.75
Reversal of lactic acidosis associated with heart failure by nitroprusside administration. Br Med J (1979) 0.75
Incorrect estimation of TB drug resistance in Israel, probably due to recruitment and collection biases. Int J Tuberc Lung Dis (2000) 0.75
Automated external defibrillators. N Engl J Med (2001) 0.75
INTERFERON-GAMMA-RELEASE ASSAY PREVENTS UNNECESSARY TUBERCULOSIS THERAPY. Isr Med Assoc J (2015) 0.75
Traveller's coccidioidomycosis: case report of pulmonary infection diagnosed in Israel. J Clin Microbiol (1992) 0.75
Expression of 17 alpha-hydroxylase and aromatase in the syndrome of androgen resistance: a case report. Gynecol Endocrinol (1996) 0.75
Chevron beam dump for ITER edge Thomson scattering system. Rev Sci Instrum (2013) 0.75
[Perhexilene maleate--a new drug for the treatment of angina pectoris]. Harefuah (1978) 0.75
MTF measurement via diffraction shearing with optically superimposed gratings. Appl Opt (1979) 0.75
The effect upon coronary blood flow of coronary ostial intubation with an angiographic catheter. Chest (1977) 0.75
Corrigendum: Growth and modelling of spherical crystalline morphologies of molecular materials. Nat Commun (2015) 0.75
[Editorial: Does the Q-Wave in the ECG symbolize myocardial necrosis?]. Harefuah (1976) 0.75
[Treatment with beta-blockers after myocardial infarction improves the long term prognosis]. Harefuah (1982) 0.75
[An experimental program for the integration of community and hospital medical services]. Harefuah (1977) 0.75
Normal parathyroid hormone activity in hypercalcemia associated with thrombotic thrombocytopenic purpura. N Engl J Med (1983) 0.75
Nonlinear optical effects in Raman calibrations of a Thomson scattering system. Appl Opt (1993) 0.75
Treadmill exercise testing. Part I. Curr Probl Cardiol (1977) 0.75